• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌术前液基细针穿刺中预测淋巴结转移风险的细胞形态学因素及BRAF突变

Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.

作者信息

Chung Soo Young, Lee Jae Seok, Lee Hyebin, Park Sung Hee, Kim Soo Jin, Ryu Han Suk

机构信息

Department of Pathology, Cancer Center, Dongnam Institute of Radiological and Medical Sciences, Busan, South Korea.

出版信息

Acta Cytol. 2013;57(3):252-8. doi: 10.1159/000343617. Epub 2013 Apr 25.

DOI:10.1159/000343617
PMID:23636013
Abstract

OBJECTIVE

Preoperative fine needle aspiration biopsy (FNAB) has become the initial diagnostic method for papillary thyroid carcinoma (PTC). Identification of cytomorphologic factors predicting lymph node metastasis (LNM) is clinically important for determining the appropriate treatment regimen due to the high rate of lymph node involvement in PTC at the time of diagnosis. Hobnail features (HF) have previously been described as potential histomorphologic features in the histological examination of PTC. This study evaluated the value of HF as a predictor of LNM.

STUDY DESIGN

Histologically confirmed FNABs (n = 111) of papillary thyroid microcarcinoma prepared by the liquid-based method were enrolled. Along with other cytomorphologic parameters, HF were evaluated for their value in predicting LNM.

RESULTS

Although HF were closely correlated with cytoplasmic vacuoles of tumor cells and background macrophages (p < 0.05), which were considered diagnostic indicators of PTC with cystic changes, HF were only found to be significantly correlated with LNM (p = 0.008). The BRAF(V660E) mutation was not associated with LNM. All combinations including HF were revealed as stronger predictors of LNM (odds ratios: 2.254-2.524, p < 0.05).

CONCLUSIONS

HF, a distinctive cytomorphologic feature, may be used as a factor predicting LNM in preoperative FNAB of PTC.

摘要

目的

术前细针穿刺活检(FNAB)已成为甲状腺乳头状癌(PTC)的初始诊断方法。由于PTC在诊断时淋巴结受累率高,识别预测淋巴结转移(LNM)的细胞形态学因素对于确定合适的治疗方案具有重要临床意义。鞋钉样特征(HF)此前已被描述为PTC组织学检查中的潜在组织形态学特征。本研究评估了HF作为LNM预测指标的价值。

研究设计

纳入通过液基方法制备的111例经组织学证实的甲状腺微小乳头状癌的FNAB。除其他细胞形态学参数外,还评估了HF在预测LNM方面的价值。

结果

尽管HF与肿瘤细胞的胞质空泡和背景巨噬细胞密切相关(p < 0.05),而这些被认为是伴有囊性改变的PTC的诊断指标,但仅发现HF与LNM显著相关(p = 0.008)。BRAF(V660E)突变与LNM无关。所有包含HF的组合均显示为更强的LNM预测指标(优势比:2.254 - 2.524,p < 0.05)。

结论

HF作为一种独特的细胞形态学特征,可作为PTC术前FNAB中预测LNM的一个因素。

相似文献

1
Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.甲状腺乳头状癌术前液基细针穿刺中预测淋巴结转移风险的细胞形态学因素及BRAF突变
Acta Cytol. 2013;57(3):252-8. doi: 10.1159/000343617. Epub 2013 Apr 25.
2
Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.术前细针穿刺活检 BRAF 分析预测甲状腺乳头状癌隐匿性中央淋巴结转移:一项前瞻性研究。
J Clin Endocrinol Metab. 2012 Nov;97(11):3996-4003. doi: 10.1210/jc.2012-2444. Epub 2012 Aug 28.
3
Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.术前 BRAF 突变对不同肿瘤大小的淋巴结转移具有不同的预测价值。
Otolaryngol Head Neck Surg. 2011 Sep;145(3):422-7. doi: 10.1177/0194599811404649. Epub 2011 Jul 12.
4
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience.术前 BRAF 分析在甲状腺乳头状癌中的应用:单中心前瞻性经验与临床病理特征及预后的相关性。
Clin Chem Lab Med. 2016 Sep 1;54(9):1531-9. doi: 10.1515/cclm-2015-0218.
5
The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.分子标志物和肿瘤组织学类型在甲状腺乳头状癌中央淋巴结转移中的作用
Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):44-9. doi: 10.1001/archoto.2011.226.
6
Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.BRAF V600E突变在传统型乳头状甲状腺癌甲状腺切除范围及淋巴结清扫中的作用
Surgery. 2015 Dec;158(6):1500-11. doi: 10.1016/j.surg.2015.05.016. Epub 2015 Jun 26.
7
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.甲状腺结节细针抽吸活检 BRAF 分析可提高术前对甲状腺乳头状癌的识别,并可作为预后因素。单机构经验。
Clin Chem Lab Med. 2011 Feb;49(2):325-9. doi: 10.1515/CCLM.2011.031. Epub 2010 Dec 23.
8
Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.利用甲状腺乳头状癌残留的常规细针穿刺标本检测BRAF基因c.1799T > A(p.V600E)突变
Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.
9
BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.甲状腺乳头状癌细针穿刺活检的BRAF突变分析:对诊断和预后的影响
Acta Cytol. 2011;55(6):563-9. doi: 10.1159/000333272. Epub 2011 Dec 9.
10
The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.BRAF 突变可预测甲状腺微小乳头状癌侵袭性临床病理特征。
Ann Surg Oncol. 2010 Dec;17(12):3294-300. doi: 10.1245/s10434-010-1129-6. Epub 2010 Oct 15.

引用本文的文献

1
Association of BRAF Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.BRAF 突变与甲状腺微小乳头状癌侵袭性行为的相关性:33 项研究的荟萃分析。
Int J Mol Sci. 2022 Dec 9;23(24):15626. doi: 10.3390/ijms232415626.
2
Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.钉突样甲状腺乳头状癌的系统评价和荟萃分析。
Endocrine. 2021 Apr;72(1):27-39. doi: 10.1007/s12020-020-02505-z. Epub 2020 Oct 6.
3
A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
一项评估B型 Raf 激酶突变与甲状腺乳头状癌颈部淋巴结转移之间关系的荟萃分析。
Medicine (Baltimore). 2020 Jan;99(5):e18917. doi: 10.1097/MD.0000000000018917.
4
BRAF mutation in papillary thyroid carcinoma (PTC) and its association with clinicopathological features and systemic inflammation response index (SIRI).甲状腺乳头状癌(PTC)中的BRAF突变及其与临床病理特征和全身炎症反应指数(SIRI)的关联。
Am J Transl Res. 2018 Aug 15;10(8):2726-2736. eCollection 2018.
5
Can liquid-based preparation substitute for conventional smear in thyroid fine-needle aspiration? A systematic review based on meta-analysis.液基制剂能否替代传统涂片用于甲状腺细针穿刺?一项基于荟萃分析的系统评价。
Endocr Connect. 2017 Nov;6(8):817-829. doi: 10.1530/EC-17-0165. Epub 2017 Oct 10.
6
BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases.甲状腺乳头状癌中的 BRAF 和 NRAS 突变与原发灶和相应淋巴结转移灶中 BRAF 突变的一致性。
Sci Rep. 2017 Jul 5;7(1):4666. doi: 10.1038/s41598-017-04948-3.
7
The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.甲状腺微小乳头状癌的遗传学:诊断及预后意义
Curr Genomics. 2017 Jun;18(3):244-254. doi: 10.2174/1389202918666170105094459.
8
BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.BRAF(V⁶⁰⁰E)突变及其与甲状腺微小乳头状癌临床病理特征的相关性:一项荟萃分析。
J Huazhong Univ Sci Technolog Med Sci. 2015 Aug;35(4):591-599. doi: 10.1007/s11596-015-1476-4. Epub 2015 Jul 31.
9
BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.甲状腺微小乳头状癌中的BRAFV600E突变:一项荟萃分析。
Endocr Relat Cancer. 2015 Apr;22(2):159-68. doi: 10.1530/ERC-14-0531. Epub 2015 Jan 15.
10
Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer.人喉癌中癌干细胞样侧群细胞的临床意义
Tumour Biol. 2013 Dec;34(6):3603-10. doi: 10.1007/s13277-013-0941-6. Epub 2013 Jun 27.